168 related articles for article (PubMed ID: 18419150)
1. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
2. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
3. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
[TBL] [Abstract][Full Text] [Related]
4. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Waanders E; Croes HJ; Maass CN; te Morsche RH; van Geffen HJ; van Krieken JH; Fransen JA; Drenth JP
Histochem Cell Biol; 2008 Mar; 129(3):301-10. PubMed ID: 18224332
[TBL] [Abstract][Full Text] [Related]
5. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease.
Janssen MJ; Waanders E; Woudenberg J; Lefeber DJ; Drenth JP
J Hepatol; 2010 Mar; 52(3):432-40. PubMed ID: 20138683
[TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease].
Jansen JB; Morsche RH; Drenth JP
Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1408-12. PubMed ID: 12894465
[TBL] [Abstract][Full Text] [Related]
7. Polycystic liver disease is a disorder of cotranslational protein processing.
Drenth JP; Martina JA; van de Kerkhof R; Bonifacino JS; Jansen JB
Trends Mol Med; 2005 Jan; 11(1):37-42. PubMed ID: 15649821
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.
Drenth JP; te Morsche RH; Smink R; Bonifacino JS; Jansen JB
Nat Genet; 2003 Mar; 33(3):345-7. PubMed ID: 12577059
[TBL] [Abstract][Full Text] [Related]
9. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.
Waanders E; van Keimpema L; Brouwer JT; van Oijen MG; Aerts R; Sweep FC; Nevens F; Drenth JP
Liver Int; 2009 Oct; 29(9):1389-95. PubMed ID: 19515221
[TBL] [Abstract][Full Text] [Related]
11. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
12. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
[TBL] [Abstract][Full Text] [Related]
13. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease.
Drenth JP; Martina JA; Te Morsche RH; Jansen JB; Bonifacino JS
Gastroenterology; 2004 Jun; 126(7):1819-27. PubMed ID: 15188177
[TBL] [Abstract][Full Text] [Related]
15. Polycystic liver and kidney diseases.
Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
[TBL] [Abstract][Full Text] [Related]
16. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
[TBL] [Abstract][Full Text] [Related]
17. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.
Van Keimpema L; De Koning DB; Van Hoek B; Van Den Berg AP; Van Oijen MG; De Man RA; Nevens F; Drenth JP
Liver Int; 2011 Jan; 31(1):92-8. PubMed ID: 20408955
[TBL] [Abstract][Full Text] [Related]
18. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of hepatocystin induces autophagy through an mTOR-dependent pathway.
Yang J; Zhao Y; Ma K; Jiang FJ; Liao W; Zhang P; Zhou J; Tu B; Wang L; Kampinga HH; Xie Z; Zhu WG
Autophagy; 2011 Jul; 7(7):748-59. PubMed ID: 21681021
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]